Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Musher and Company, founded by brothers Albert and Sidney Musher, was a pioneering research and development firm focused on the intersection of food chemistry and pharmaceuticals. The company is most recognized for developing the colloidal oatmeal technology that serves as the basis for the Aveeno brand of dermatological products. Sidney Musher, a prolific inventor, held numerous patents for antioxidants and stabilizers derived from cereal grains, which significantly advanced the field of topical skin treatments. Their research, conducted in collaboration with institutions like the Mayo Clinic, provided the first clinical evidence for the efficacy of oat-based treatments in managing skin conditions. Although the Aveeno brand was later acquired by Johnson & Johnson, the Mushers' research legacy persists through the Musher Foundation and various academic endowments. Their work remains a foundational element in the history of natural-based clinical skincare and the application of food-derived compounds in medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Albert and Sidney Musher.